Real World Evidence. Real Results.
Discover technology-enabled approaches to generate cost-effective evidence at scale
Real world evidence (RWE) is increasingly being used across the product lifecycle, shaping trial strategy and design, influencing regulatory decision making, and demonstrating commercial differentiation and drug value. Join our upcoming series to discover more about how you can:
- Maximise value from RWE generation with an Integrated Evidence Strategy that supports end-to-end, multi-stakeholder needs
- Incorporate patient centricity as a true strategic catalyst
- Leverage the latest technologies and direct-to-patient innovations to enable faster, more efficient evidence generation for real world studies
- Discover how technology-enabled analytics, natural language processing, and AI/ML can better inform decision making
Session 4: Game-changing evidence approaches: Lessons from COVID for life sciences and beyond
- How the evidence landscape is evolving, what it means for the healthcare industry, and how it impacts our return to work, sports, and normal life?
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.